Trulieve anticipates at least $225M in 2026 operating cash flow while raising capex outlook to $95M (NYSE:TRLV)
Trulieve (TRLV) Q2 2026 earnings call highlights: NYSE uplisting, 280E repeal impact, guidance, cash flow, and Texas/Georgia growthâread now.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Trulieve (TRLV) Q2 2026 earnings call highlights: NYSE uplisting, 280E repeal impact, guidance, cash flow, and Texas/Georgia growthâread now.
Trulieve anticipates at least $225M in 2026 operating cash flow while raising capex outlook to $95M (NYSE:TRLV) | Seeking Alpha
Earnings Call Insights: Trulieve Cannabis Corp. (TRLV) Q2 2026
Management View
âWe are thrilled to report second quarter results for the first time as a company listed on the New York Stock Exchange.â (Founder, Chairman & CEO Kimberly Rivers)
âIn
Seeking Alpha's Disclaimer:
This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Quick Insights
How does NYSE listing and deconsolidation affect Trulieve's financial outlook?
The NYSE listing and Harvest deconsolidation resulted in changes to consolidated revenue, a significant one-time net loss for Q2 due to the deconsolidation, and guidance transitioning to a medical-only basis; Trulieve expects continued strong cash flow and investments focused on medical operations.
What are the growth and revenue expectations for Trulieve's medical marijuana business, especially in Georgia and Texas?
Trulieve forecasts Q3 revenue comparable to $222 million (medical-only basis) and full-year operating cash flow of at least $225 million, with growth opportunities in Georgia and Texas contingent on resolving product shortages, expanding supply, and regulatory approvals.
What near-term risks could impact Trulieve's operations and financial performance?
Key near-term risks include product shortages in Georgia, variable gross margins due to product/market mix, and regulatory timing in Texas, as execution depends on supply, demand ramp, and state licensing processes.
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Solana Company Stakes 500K SOL on Tokyo Cluster, Validator Rewards Expected by Q3 2026
A Solana infrastructure firm has pledged 500,000 SOL to support its Tokyo cluster, with first validator rewards projected for Q3 2026, signaling confidence in network decentralization and Asian expansion.
Barfresh outlines $23M-$26M FY2026 revenue outlook while targeting partial commissioning of Defiance plant by end of 2026 (NASDAQ:BRFH)
Barfresh (BRFH) Q2 2026 earnings call recap: Arps-driven revenue growth, production ramp issues, and revised FY2026 guidance.
Sidus Fortis VPX Commercial Launch in 2027 Backed by $158.5M Funding
Sidus Space announces the commercial availability of its Fortis VPX edge computing module by early 2027, supported by $158.5M raised in Q2 2025. Learn about its technology advantages, market outlook, and financial health.
TOMI Reaffirms 2026 Revenue Guidance of at Least $12M, Sets $10M Funding Goal for Carbonium Core Merger
TOMI Environmental Solutions reaffirms its 2026 revenue guidance of at least $12 million and advances its merger with Carbonium Core, targeting $10 million in funding. This article analyzes the strategic implications, industry context, and potential risks.
